Director I, siRNA Discovery Research
abbvie
Umowa o pracęPełny etatOpublikowano 8 października 2026
Źródło: About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
This role will serve as a key scientific and strategic leader within BGM, shaping AbbVie's siRNA discovery portfolio and enabling the successful translation of RNAi technologies into differentiated therapeutic candidates across multiple Therapeutic Areas.
Lead the advancement and expansion of a cross-therapeutic siRNA portfolio by leveraging and evolving AbbVie's established RNAi capabilities, driving asset strategy, and partnering closely with Therapeutic Areas to identify, prioritize, and advance high-value opportunities. This leader will direct a multidisciplinary team of 10+ scientists and drive scientific, portfolio, and organizational decisions that accelerate the progression of siRNA medicines from concept to development candidates.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
This role will serve as a key scientific and strategic leader within BGM, shaping AbbVie's siRNA discovery portfolio and enabling the successful translation of RNAi technologies into differentiated therapeutic candidates across multiple Therapeutic Areas.
Lead the advancement and expansion of a cross-therapeutic siRNA portfolio by leveraging and evolving AbbVie's established RNAi capabilities, driving asset strategy, and partnering closely with Therapeutic Areas to identify, prioritize, and advance high-value opportunities. This leader will direct a multidisciplinary team of 10+ scientists and drive scientific, portfolio, and organizational decisions that accelerate the progression of siRNA medicines from concept to development candidates.
